Cargando…
Endocannabinoid system in cardiovascular disorders - new pharmacotherapeutic opportunities
The long history of Cannabis sativa had its development stimulated and oriented for medicine after the discovery and chemical characterization of its main active ingredient, the 9-tetrahydrocannabinol (9-THC). Consequently, a binding site for 9-THC was identified in rat brains and the first cannabin...
Autores principales: | Cunha, Pedro, Romão, Ana M., Mascarenhas-Melo, Filipa, Teixeira, Helena M., Reis, Flávio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications Pvt Ltd
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3178941/ https://www.ncbi.nlm.nih.gov/pubmed/21966155 http://dx.doi.org/10.4103/0975-7406.84435 |
Ejemplares similares
-
Depression as an Immunometabolic Disorder: Exploring Shared Pharmacotherapeutics with Cardiovascular Disease
por: Chávez-Castillo, Mervin, et al.
Publicado: (2020) -
Anticoronavirus and Immunomodulatory Phenolic Compounds: Opportunities and Pharmacotherapeutic Perspectives
por: Dejani, Naiara Naiana, et al.
Publicado: (2021) -
G2/M inhibitors as pharmacotherapeutic opportunities for glioblastoma: the old, the new, and the future
por: Castro-Gamero, Angel Mauricio, et al.
Publicado: (2018) -
New Markers of Early Cardiovascular Risk in Multiple Sclerosis Patients: Oxidized-LDL Correlates with Clinical Staging
por: Palavra, Filipe, et al.
Publicado: (2013) -
Markers of Increased Cardiovascular Risk in Postmenopausal Women: Focus on Oxidized-LDL and HDL Subpopulations
por: Mascarenhas-Melo, Filipa, et al.
Publicado: (2013)